Active - Proposal to Strike off13740530Private limited companySwansea

ABCLONAL UK LIMITED

Significant control: Wuhan Abclonal Biotechnology Co., Ltd (75–100%)

Proposal to strike offThe registrar has published a notice proposing to remove this company from the register. Unless the cause is dealt with or an objection is upheld, it can be dissolved. Status as shown on the Companies House register at 31 August 2026; it may have changed since. Check the live record.
Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Abclonal UK Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Abclonal UK Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

ABCLONAL UK LIMITED is an active (proposal to strike off) private limited company (company number 13740530) incorporated on 12 November 2021, registered in Swansea. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024, showing net assets of −£305k and cash of £846, with 1 employee on average. Net assets rose 3% on the prior period (−£315k).

Peer position · net assets

By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).

02

Ownership and control

1 active · 2 other
  • Wuhan Abclonal Biotechnology Co., Ltd
    corporate entity · since 7 April 2022
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Mr Xiao Peng
    Individual · since 12 November 2021 · ceased 3 March 2022
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Peggrem Shaun
    Individual · since 3 March 2022 · ceased 7 April 2022
    • owns 75–100% of shares

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
12 November 20214 yrs ago
Next accounts due
30 September 202627 days overdue
Confirmation statement due
26 November 2026in 30 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
SIC 82990
Other business support service activities n.e.c.
Accounts type
Small
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2024
Net assets
−£305k
vs Dec 2023
Cash at bank
£846
−99%vs Dec 2023
Turnover
Not reported
Employees
1
−80%vs Dec 2023
Net assets
−£305k
Cash at bank
£846
Average employees
1
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2024−£305k£846£27k———1
31 December 2023−£315k£108k£32k———5
Cash per employee£846Cash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets below zeroNet assets £-305,408 at 31 December 2024
  • Incorporated two to five years agoIncorporated 12 November 2021
  • Register status is not ActiveActive - Proposal to Strike off

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 30 days
  2. Next accounts due27 days overdue
  3. Accounts period endNet liabilities £305k · small accounts
  4. Accounts period endNet liabilities £315k · small accounts
  5. Incorporated
08

Similar companies in Swansea

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for ABCLONAL UK LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown. Contact us about this company.